• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿蛋白包涵体不会消耗HD小鼠中含多聚谷氨酰胺的转录因子。

Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice.

作者信息

Yu Zhao-Xue, Li Shi-Hua, Nguyen Huu-Phuc, Li Xiao-Jiang

机构信息

Department of Human Genetics, Emory University, School of Medicine, Atlanta, GA 30322, USA.

出版信息

Hum Mol Genet. 2002 Apr 15;11(8):905-14. doi: 10.1093/hmg/11.8.905.

DOI:10.1093/hmg/11.8.905
PMID:11971872
Abstract

A pathological hallmark of polyglutamine diseases is the presence of inclusions or aggregates of the expanded polyglutamine protein. Polyglutamine inclusions are present in the neuronal nucleus in a number of inherited neurodegenerative disorders, including Huntington disease (HD). Recent studies suggest that polyglutamine inclusions may sequester polyglutamine-containing transcription factors and deplete their concentration in the nucleus, leading to altered gene expression. To test this hypothesis, we examined the expression and localization of the polyglutamine-containing or glutamine-rich transcription factors TBP, CBP and Sp1 in HD mouse models. All three transcription factors were diffusely distributed in the nucleus, despite the presence of abundant intranuclear inclusions. There were no differences in the nuclear staining of these transcription factors between HD and wild-type mouse brains. Although some CBP staining appeared as dots in the selective brain regions (e.g. hypothalamus and amygdala), double labeling showed that most CBP was not co-localized with huntingtin nuclear inclusions. Electron microscopy confirmed that CBP was diffusely distributed in the nucleus. Western blots showed that these transcription factors were not trapped in huntingtin inclusions. In the striatum of HD mice, which suffers a significant reduction in the expression of a number of genes, mutant huntingtin was present in both an aggregated and a diffuse form. These findings suggest that altered gene expression may result from the interactions of soluble mutant huntingtin with nuclear transcription factors, rather than from the depletion of transcription factors by nuclear inclusions.

摘要

多聚谷氨酰胺疾病的一个病理特征是存在扩展的多聚谷氨酰胺蛋白的包涵体或聚集体。多聚谷氨酰胺包涵体存在于多种遗传性神经退行性疾病的神经元细胞核中,包括亨廷顿舞蹈病(HD)。最近的研究表明,多聚谷氨酰胺包涵体可能隔离含多聚谷氨酰胺的转录因子并耗尽其在细胞核中的浓度,从而导致基因表达改变。为了验证这一假设,我们在HD小鼠模型中检测了含多聚谷氨酰胺或富含谷氨酰胺的转录因子TBP、CBP和Sp1的表达及定位。尽管存在大量核内包涵体,但所有这三种转录因子均在细胞核中呈弥散分布。HD小鼠脑与野生型小鼠脑之间这些转录因子的核染色没有差异。虽然在某些脑区(如下丘脑和杏仁核)一些CBP染色呈点状,但双重标记显示大多数CBP并不与亨廷顿蛋白核包涵体共定位。电子显微镜证实CBP在细胞核中呈弥散分布。蛋白质印迹分析表明这些转录因子并未被困在亨廷顿蛋白包涵体中。在许多基因表达显著降低的HD小鼠纹状体中,突变型亨廷顿蛋白以聚集和弥散两种形式存在。这些发现表明,基因表达改变可能是由于可溶性突变型亨廷顿蛋白与核转录因子的相互作用,而非核包涵体导致转录因子耗竭所致。

相似文献

1
Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice.亨廷顿蛋白包涵体不会消耗HD小鼠中含多聚谷氨酰胺的转录因子。
Hum Mol Genet. 2002 Apr 15;11(8):905-14. doi: 10.1093/hmg/11.8.905.
2
Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.亨廷顿蛋白和萎缩素-1对CBP介导的转录产生干扰,从而导致细胞毒性。
Science. 2001 Mar 23;291(5512):2423-8. doi: 10.1126/science.1056784.
3
Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.突变亨廷顿蛋白的淀粉样蛋白形成:阈值、渐进性及正常多聚谷氨酰胺蛋白的募集
Somat Cell Mol Genet. 1998 Jul;24(4):217-33. doi: 10.1023/b:scam.0000007124.19463.e5.
4
Interaction of Huntington disease protein with transcriptional activator Sp1.亨廷顿舞蹈症蛋白与转录激活因子Sp1的相互作用。
Mol Cell Biol. 2002 Mar;22(5):1277-87. doi: 10.1128/MCB.22.5.1277-1287.2002.
5
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.Sp1和TAFII130转录活性在早期亨廷顿舞蹈病中受到破坏。
Science. 2002 Jun 21;296(5576):2238-43. doi: 10.1126/science.1072613. Epub 2002 May 2.
6
HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE).HAP1可通过与保守的TBP(核心区域)特异性相互作用,将一部分TBP隔离在细胞质内含物中。
BMC Mol Biol. 2007 Sep 14;8:76. doi: 10.1186/1471-2199-8-76.
7
Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain.对从小鼠和人类大脑中分离出的亨廷顿蛋白细丝进行的生化、超微结构及可逆性研究。
J Neurosci. 2004 Oct 20;24(42):9361-71. doi: 10.1523/JNEUROSCI.2365-04.2004.
8
Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.亨廷顿舞蹈病核内包涵体含有截短的、泛素化的亨廷顿蛋白。
Exp Neurol. 1999 Mar;156(1):92-9. doi: 10.1006/exnr.1998.7005.
9
CREB-binding protein sequestration by expanded polyglutamine.扩展型多聚谷氨酰胺对CREB结合蛋白的隔离作用
Hum Mol Genet. 2000 Sep 1;9(14):2197-202. doi: 10.1093/hmg/9.14.2197.
10
Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation.多聚谷氨酰胺扩展蛋白的细胞毒性:转录因子失活机制
Mol Cell. 2004 Jul 2;15(1):95-105. doi: 10.1016/j.molcel.2004.06.029.

引用本文的文献

1
Self-driving microscopy detects the onset of protein aggregation and enables intelligent Brillouin imaging.自动驾驶显微镜可检测蛋白质聚集的起始,并实现智能布里渊成像。
Nat Commun. 2025 Jul 24;16(1):6699. doi: 10.1038/s41467-025-60912-0.
2
Label-free identification of protein aggregates using deep learning.使用深度学习进行无标记蛋白质聚集体的识别。
Nat Commun. 2023 Nov 28;14(1):7816. doi: 10.1038/s41467-023-43440-7.
3
Determining the Fate of Neurons in SCA3: ATX3, a Rising Decision Maker in Response to DNA Stresses and Beyond.
确定脊髓小脑共济失调3型中神经元的命运:ATX3,应对DNA应激及其他情况的新兴决定因素
Front Cell Dev Biol. 2020 Dec 23;8:619911. doi: 10.3389/fcell.2020.619911. eCollection 2020.
4
Protein Co-Aggregation Related to Amyloids: Methods of Investigation, Diversity, and Classification.蛋白质共聚集与淀粉样物相关:研究方法、多样性和分类。
Int J Mol Sci. 2018 Aug 4;19(8):2292. doi: 10.3390/ijms19082292.
5
The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.亨廷顿舞蹈症细胞模型中早期转录变化和聚集体形成的动力学
BMC Genomics. 2017 May 12;18(1):373. doi: 10.1186/s12864-017-3745-z.
6
Prions, amyloids, and RNA: Pieces of a puzzle.朊病毒、淀粉样蛋白与RNA:谜题的碎片
Prion. 2016 May 3;10(3):182-206. doi: 10.1080/19336896.2016.1181253.
7
Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.亨廷顿舞蹈症中的转录、表观遗传学及改善策略:全基因组视角
Mol Neurobiol. 2015 Feb;51(1):406-23. doi: 10.1007/s12035-014-8715-8. Epub 2014 May 1.
8
Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis.亨廷顿舞蹈症中的转录失调:适应性转录稳态的失败
Drug Discov Today. 2014 Jul;19(7):956-62. doi: 10.1016/j.drudis.2014.03.016. Epub 2014 Mar 21.
9
Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.赖氨酸乙酰转移酶 CBP 和 p300 作为认知和神经退行性疾病的治疗靶点。
Curr Pharm Des. 2013;19(28):5051-64. doi: 10.2174/13816128113199990382.
10
Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.甲基化胞嘧啶水平升高和羟甲基化胞嘧啶水平降低与亨廷顿病纹状体 A2AR 水平降低有关。
Neuromolecular Med. 2013 Jun;15(2):295-309. doi: 10.1007/s12017-013-8219-0. Epub 2013 Feb 6.